We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Ironwood Pharmaceuticals
IRWD
$714M
| $2.15M | ﹤0.01% |
191,987
-10,418
| -5% | -$110K |
|
1877
Sinclair Inc
SBGI
$1.03B
| $2.14M | ﹤0.01% |
73,085
-8,496
| -10% | -$283K |
|
1878
Hanmi Financial
HAFC
$946M
| $2.13M | ﹤0.01% |
108,170
+730
| +0.7% | +$11.8K |
|
1879
Ethan Allen Interiors
ETD
$603M
| $2.13M | ﹤0.01% |
77,242
-652
| -0.8% | -$16.4K |
|
1880
Primoris Services
PRIM
$4.45B
| $2.13M | ﹤0.01% |
64,237
-5,668
| -8% | -$187K |
|
|
DRNA
1881
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.13M | ﹤0.01% |
83,217
-5,614
| -6% | -$143K |
|
1882
Revolution Medicines
RVMD
$44B
| $2.1M | ﹤0.01% |
45,794
-533
| -1% | -$23.9K |
|
|
CMO
1883
DELISTED
Capstead Mortgage Corp.
CMO
| $2.1M | ﹤0.01% |
336,427
+4,587
| +1% | +$27K |
|
1884
Blackstone
BX
$110B
| $2.09M | ﹤0.01% |
28,093
-3,146
| -10% | -$217K |
|
1885
Delek US
DK
$3.58B
| $2.09M | ﹤0.01% |
96,142
-8,283
| -8% | -$181K |
|
|
SC
1886
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.09M | ﹤0.01% |
77,201
-4,287
| -5% | -$107K |
|
|
SCS
1887
DELISTED
Steelcase
SCS
| $2.09M | ﹤0.01% |
144,978
-11,345
| -7% | -$161K |
|
1888
Red Robin
RRGB
$152M
| $2.08M | ﹤0.01% |
52,205
+22
| +0% | +$665 |
|
|
BRMK
1889
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $2.08M | ﹤0.01% |
198,952
-16,491
| -8% | -$173K |
|
1890
Anika Therapeutics
ANIK
$287M
| $2.07M | ﹤0.01% |
50,726
+2,181
| +4% | +$82.7K |
|
1891
National Presto Industries
NPK
$989M
| $2.07M | ﹤0.01% |
20,257
+359
| +2% | +$35.3K |
|
1892
Inovio Pharmaceuticals
INO
$69M
| $2.07M | ﹤0.01% |
18,551
+1,439
| +8% | +$189K |
|
1893
DXP Enterprises
DXPE
$2.98B
| $2.06M | ﹤0.01% |
68,418
-354
| -0.5% | -$10.1K |
|
|
ZUO
1894
DELISTED
Zuora, Inc.
ZUO
| $2.06M | ﹤0.01% |
139,223
+8,601
| +7% | +$128K |
|
|
PFC
1895
DELISTED
Premier Financial Corp. Common Stock
PFC
| $2.06M | ﹤0.01% |
61,833
-4,395
| -7% | -$130K |
|
1896
HealthStream
HSTM
$840M
| $2.05M | ﹤0.01% |
91,931
+994
| +1% | +$23.7K |
|
1897
Seaboard Corp
SEB
$4.06B
| $2.05M | ﹤0.01% |
556
-17
| -3% | -$57K |
|
1898
Columbus McKinnon
CMCO
$584M
| $2.05M | ﹤0.01% |
38,836
-1,778
| -4% | -$84.8K |
|
1899
Insteel Industries
IIIN
$625M
| $2.05M | ﹤0.01% |
66,341
+1,047
| +2% | +$31.2K |
|
|
FLNA
1900
Filana Therapeutics
FLNA
$48.1M
| $2.04M | ﹤0.01% |
45,438
+11,448
| +34% | +$450K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.